At a glance
ClinicalIndex Comparison RecordN/ACompleted· 409 enrolled
Drug / intervention
0.454% w/w stannous fluoride (1100ppm fluoride) +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Short Term Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity
In Brief
A clinical study evaluating 0.454% w/w stannous fluoride (1100ppm fluoride) and 0.76% sodium monofluorophosphate (1000ppm fluoride) for Dentin Sensitivity. Completed, enrolled 409 participants across 3 sites.
Detailed Summary
This study will investigate the efficacy of an experimental dentifrice containing 0.454% weight/weight (w/w) stannous fluoride in relieving dentine hypersensitivity (DH) after twice daily brushing, over a 2 week treatment period compared with a standard fluoride dentifrice.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDentin Sensitivity
CountriesUnited Kingdom
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartMar 2016
First PostedMar 2016
Primary CompletionMay 2016
TodayJul 2026
First PostedMar 10, 2016
Enrollment StartMar 1, 2016
Primary CompletionMay 20, 2016
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 10.3 years ago
Interventions
0.454% w/w stannous fluoride (1100ppm fluoride)other
Dentifrice containing 0.454% w/w stannous fluoride (1100ppm fluoride)
0.76% sodium monofluorophosphate (1000ppm fluoride)other
Dentifrice containing 0.76% sodium monofluorophosphate (1000ppm fluoride)